C4 Therapeutics (CCCC) Debt Ratio (2020 - 2023)

C4 Therapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.06 for Q2 2023.

• In Q2 2023, Debt Ratio rose 144.06% year-over-year to 0.06; the TTM figure through Jun 2023 stood at 0.06 (up 144.06% YoY), while the FY2022 annual figure was 0.03, up 25.42% from the prior year.
• Debt Ratio for Q2 2023 stood at 0.06, up from 0.04 in the prior quarter.
• The five-year high for Debt Ratio was 0.06 in Q2 2023, with the low at 0.02 in Q2 2021.
• The 4-year median for Debt Ratio is 0.02 (2020), against an average of 0.03.
• The sharpest annual moves came in 2021 and 2023: Debt Ratio sank 51.64% in 2021, then soared 144.06% in 2023.
• C4 Therapeutics' Debt Ratio stood at 0.03 in 2020, then fell by 15.42% to 0.02 in 2021, then advanced by 25.42% to 0.03 in 2022, then soared by 106.82% to 0.06 in 2023.
• Business Quant data shows CCCC's Debt Ratio at 0.06 in Q2 2023, 0.04 in Q1 2023, and 0.03 in Q4 2022.